Cardiac and Kidney Markers for Cardiovascular Prediction in Individuals With Chronic Kidney Disease

Estimated Glomerular Filtration Rate and Albuminuria as Predictors of Outcomes in Patients With High Cardiovascular Risk

(2013) Catherine M. Clase   ANNALS OF INTERNAL MEDICINE

Novel Markers of Kidney Function as Predictors of ESRD, Cardiovascular Disease, and Mortality in the General Population

(2012) Brad C. Astor et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Prognostic Utility of Novel Biomarkers of Cardiovascular Stress

(2012) Thomas J. Wang et al.   CIRCULATION

Combined Association of Creatinine, Albuminuria, and Cystatin C with All-Cause Mortality and Cardiovascular and Kidney Outcomes

(2012) S. Waheed et al.   Clinical Journal of the American Society of Nephrology

High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate

(2012) Lieneke Scheven et al.   EUROPEAN HEART JOURNAL

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients

(2012) Sophie Liabeuf et al.   KIDNEY INTERNATIONAL

Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study

(2012) Marcello Tonelli et al.   LANCET

C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C

(2012) Lesley A. Inker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Developing and assessing cardiovascular biomarkers

(2012) Razvan T. Dadu et al.   Translational Research

The Effect of Including Cystatin C or Creatinine in a Cardiovascular Risk Model for Asymptomatic Individuals: The Multi-Ethnic Study of Atherosclerosis

(2011) H. Ito et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study

(2011) Justin T. Saunders et al.   CIRCULATION

Detection of Chronic Kidney Disease With Creatinine, Cystatin C, and Urine Albumin-to-Creatinine Ratio and Association With Progression to End-Stage Renal Disease and Mortality

(2011) Carmen A. Peralta   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Beta 2 Microglobulin and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid Atherosclerosis

(2011) Jasmin Amighi et al.   STROKE

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

(2010)   LANCET

Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community

(2009) Olle Melander   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

β2-Microglobulin for Risk Stratification of Total Mortality in the Elderly PopulationComparison With Cystatin C and C-Reactive Protein

(2008) Shoji Shinkai   ARCHIVES OF INTERNAL MEDICINE

N-Terminal Prohormone Brain Natriuretic Peptide as a Predictor of Cardiovascular Disease and Mortality in Blacks With Hypertensive Kidney Disease

(2008) B.C. Astor et al.   CIRCULATION

Media Calcification and Intima Calcification Are Distinct Entities in Chronic Kidney Disease

(2008) K. Amann   Clinical Journal of the American Society of Nephrology

Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes

(2008) Björn Zethelius et al.   NEW ENGLAND JOURNAL OF MEDICINE

Statin Induced Myopathy and Myalgia: Time Trend Analysis and Comparison of Risk Associated with Statin Class from 1991–2006

(2008) Mariam Molokhia et al.   PLoS One